ArticleAntimicrobial agents and chemotherapy2005

DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.

Jacob Strahilevitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.